Diality Closes $24 Million of Series B2 Financing to Support Regulatory Clearance and Market Entry for its Versatile Hemodialysis System

IRVINE, Calif., March 2, 2022 /PRNewswire/ -- Diality, Inc. (https://www.diality.com), a medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, announced the close of a $24 million Series B2...

Click to view original post